BRIEF-Catalyst Pharmaceuticals FY Revenue USD 491.7 Million Vs. IBES Estimate USD 484.1 Million

Reuters
27 Feb
BRIEF-Catalyst Pharmaceuticals FY Revenue USD 491.7 Million Vs. IBES Estimate USD 484.1 Million

Feb 26 (Reuters) - Catalyst Pharmaceuticals FY net income USD 163.9 million.

  • FY operating income USD 195.1 million vs. IBES estimate USD 183.8 million
  • FY adjusted net income USD 81.5 million vs. IBES estimate USD 167.9 million
  • outlook FY revenue USD 545-565 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10